Cyclopharm Limited (ASX:CYC)
Australia
· Delayed Price · Currency is AUD 1.130
-0.010 (-0.88%)
Apr 28, 2025, 4:10 PM AEST
Cyclopharm Cash Flow Statement
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -13.2 | -4.7 | -6.61 | -5.04 | -6.04 | Upgrade
|
| Depreciation & Amortization | 1.48 | 0.94 | 0.93 | 0.76 | 0.91 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | -3.16 | - | - | - | Upgrade
|
| Other Operating Activities | 1.75 | 0.9 | 0.52 | 0.75 | 1.01 | Upgrade
|
| Change in Accounts Receivable | 0.84 | -0.49 | -0.59 | 0.69 | -1.78 | Upgrade
|
| Change in Inventory | -3.09 | -1.86 | -2.78 | -0.78 | -2.24 | Upgrade
|
| Change in Accounts Payable | 0.27 | 0.93 | 0.89 | 1.45 | 2.13 | Upgrade
|
| Change in Unearned Revenue | - | - | 0 | 0 | 0.1 | Upgrade
|
| Change in Income Taxes | -0.19 | -0.05 | 0.04 | 0.16 | 0.08 | Upgrade
|
| Change in Other Net Operating Assets | -0.45 | 0.42 | 0.74 | 0.02 | -3.12 | Upgrade
|
| Operating Cash Flow | -12.57 | -7.2 | -6.66 | -1.63 | -8.93 | Upgrade
|
| Capital Expenditures | -0.8 | -0.24 | -1.27 | -0.84 | -0.19 | Upgrade
|
| Cash Acquisitions | - | 0.03 | - | - | -0.34 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.17 | -0.3 | -0.27 | -0.32 | -0.34 | Upgrade
|
| Investing Cash Flow | -0.97 | -0.51 | -1.55 | -1.16 | -0.87 | Upgrade
|
| Long-Term Debt Repaid | -0.64 | -0.28 | -0.29 | -0.29 | -0.29 | Upgrade
|
| Net Debt Issued (Repaid) | -0.64 | -0.28 | -0.29 | -0.29 | -0.29 | Upgrade
|
| Issuance of Common Stock | 24.01 | 0.14 | 0.45 | 33 | 0.06 | Upgrade
|
| Common Dividends Paid | - | -0.88 | -0.88 | -0.88 | -0.75 | Upgrade
|
| Other Financing Activities | -1.14 | - | - | -1.66 | - | Upgrade
|
| Financing Cash Flow | 22.22 | -1.02 | -0.73 | 30.17 | -0.99 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.17 | 0.16 | -0.01 | -0.01 | 0.01 | Upgrade
|
| Net Cash Flow | 8.84 | -8.57 | -8.95 | 27.37 | -10.79 | Upgrade
|
| Free Cash Flow | -13.38 | -7.43 | -7.94 | -2.47 | -9.13 | Upgrade
|
| Free Cash Flow Margin | -48.52% | -28.23% | -31.94% | -12.36% | -51.63% | Upgrade
|
| Free Cash Flow Per Share | -0.13 | -0.08 | -0.09 | -0.03 | -0.12 | Upgrade
|
| Cash Interest Paid | 0.32 | 0.32 | 0.27 | 0.09 | 0.21 | Upgrade
|
| Cash Income Tax Paid | 0.3 | 0.3 | -3.42 | -2.73 | 0.25 | Upgrade
|
| Levered Free Cash Flow | -10.21 | -6.63 | -5.97 | -0.81 | -7.31 | Upgrade
|
| Unlevered Free Cash Flow | -10.03 | -6.51 | -5.8 | -0.75 | -7.18 | Upgrade
|
| Change in Net Working Capital | 1.82 | 1.17 | 2.09 | -1.81 | 4.93 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.